Myriad Genetics reported $130.5M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Accelerate Diagnostics AXDX:US USD 8.25M 3.24M
Agilent A:US USD 422M 10M
Becton, Dickinson and BDX:US USD 1.18B 33M
Bio Rad Laboratories BIO:US USD 208.25M 483K
Biocept BIOC:US USD 4.02M 1.93M
Bruker BRKR:US USD 144.8M 7.4M
Danaher DHR:US USD 2.15B 64M
Exact Sciences EXAS:US USD 379.66M 17.93M
Fluidigm FLDM:US USD 29.6M 787K
Hologic HOLX:US USD 256.5M 12.3M
Illumina ILMN:US USD 146M 264M
Johnson & Johnson JNJ:US USD 6.09B 137M
Mettler Toledo International MTD:US USD 233.36M 8.85M
Myriad Genetics MYGN:US USD 130.5M 3.4M
Nanostring Technologies NSTG:US USD 33.77M 2.34M
Orasure Technologies OSUR:US USD 29M 262K
Pacific Biosciences Of California PACB:US USD 36.8M 2.46M
Perkinelmer PKI:US USD 239.97M 68.16M
Quest Diagnostics DGX:US USD 457M 43M
Repligen RGEN:US USD 53.64M 1.01M
Thermo Fisher Scientific TMO:US USD 1.74B 466M
Veracyte VCYT:US USD 42.73M 2.77M
Waters WAT:US USD 164.42M 2.54M